Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Phenazopyridine hydrochloride (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 95 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 97.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing oxytetracycline hydrochloride and phenazopyridine hydrochloride and sulfamethizole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing phenazopyridine hydrochloride and sulfamethoxazole and trimethoprim |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phenazopyridine hydrochloride 95 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 95 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 150 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 97.2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 97.2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 97.2 mg oral tablet |
Has precise active ingredient |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 100 mg oral tablet |
Has precise active ingredient |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg oral tablet |
Has precise active ingredient |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has precise active ingredient |
False |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 150 mg oral tablet |
Has precise active ingredient |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 95 mg oral tablet |
Has precise active ingredient |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has precise active ingredient |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Phenazopyridine hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |